Results 261 to 270 of about 251,997 (330)

Evaluation of relative biological effectiveness of ²²⁵Ac and its decay daughters with Monte Carlo track structure simulations. [PDF]

EJNMMI Phys
Hu Z, Qu S, Liu H, Zhang Y, Yan S, Hu A, Qiu R, Wu Z, Zhang H, Li J.   +9 more
europepmc   +1 more source

Effect of oxygen in sodium upon radionuclide release from austenitic stainless steel

, 1975
W.F. Brehm
openalex   +1 more source

Nationwide mapping of terrestrial gamma radiation in South Korea using a car-borne survey system. [PDF]

Sci Rep
Jang J, Park J, Chang BU, Kim YJ.
europepmc   +1 more source

Optimized cementitious immobilization of simulated cesium and barium radionuclides in borate waste solution by natural zeolite additives

Gabriel Iklaga, Nándor Kaposy, István Tolnai, Zsolt E. Horváth, Zoltán Kovács, Nedson Theonest Kashaija, Viktória Gável, Csaba Szabó, Margit Fábián, Zsuzsanna Szabó-Krausz, Péter Völgyesi   +10 more
openalex   +1 more source

Projected external doses from an accidental release of ESS spallation-target products: time-dependence and radionuclide contribution. [PDF]

Radiat Prot Dosimetry
Rääf C, Frost R, Bernhardsson C, Pédehontaa-Hiaa G.   +3 more
europepmc   +1 more source

Radionuclides.

Canadian Urological Association journal = Journal de l'Association des urologues du Canada
Anil, Kapoor, Sebastien J, Hotte
openaire   +1 more source

Affibody Molecule-mediated Radionuclide Therapy of HER2-expressing Cancers

Yongsheng Liu
openalex   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Theranostic Nuclear Medicine with Gallium-68, Lutetium-177, Copper-64/67, Actinium-225, and Lead-213/203 Radionuclides.

Chemical Reviews, 2023
Molecular changes in malignant tissue can lead to an increase in the expression levels of various proteins or receptors that can be used to target the disease.
Katherine A Morgan, S. Rudd, Asif Noor, Paul S Donnelly   +3 more
semanticscholar   +1 more source

Radionuclide Therapy

Clinical Oncology, 1999
Nuclear medicine therapy uses unsealed radioactive sources for the selective delivery of radiation to tumours or target organs. For benign disorders such as thyrotoxicosis and arthritis radionuclide therapy provides an alternative to surgery or medical treatment.
R B, Buchanan, V J, Lewington
openaire   +5 more sources